Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19

M. Haq, A. Rehman, M. Haq, Hala Haq, Hala Rajab, Junaid Ahmad, J. Ahmed, Saeed Anwar, Sajjad Ahmad, N. Haq
{"title":"Identifying higher risk subgroups of health care workers for priority vaccination against COVID-19","authors":"M. Haq, A. Rehman, M. Haq, Hala Haq, Hala Rajab, Junaid Ahmad, J. Ahmed, Saeed Anwar, Sajjad Ahmad, N. Haq","doi":"10.1177/25151355221080724","DOIUrl":null,"url":null,"abstract":"Background: Health care workers (HCWs) are exposed to high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to close contact with infected patients in hospital. The objective of this study was to estimate the seroprevalence and to identify the exposure risk of various subgroups among HCWs to prioritize them for early vaccination. Methods: This was a multicentre cross-sectional study conducted between 15 and 29 June 2020. A total of 987 HCWs were recruited randomly from two major tertiary-care hospitals of Peshawar city, Pakistan. The HCWs included doctors, nurses, paramedics and hospital support staff. The US Food and Drug Administration (FDA)–approved kit was used for the detection of SARS-CoV-2 antibodies. Results: Overall, 310 (31.4%) HCWs were seropositive for SARS-CoV-2 antibodies (95% confidence interval, CI: 28.5–34.4). Seroprevalence was higher in males (33.5%) and in age group 51–60 years (40.9%). Seropositivity increased with increasing age from 8.3% in age group ⩽20 to 40.9% in 51–60 years of age group (p < 0.05). The highest seroprevalence was identified in paramedical staff (42·5%, 95% CI: 36.6–48.6) followed by nursing staff (38·8%, 95% CI: 32.1–45.7). In logistic regression, being a male HCW led to higher risk of seropositivity (odds ratio, OR: 1.50, 95% CI: 1·06–2.13. p < 0.05) compared with female staff members. The odds of seropositivity was higher in nurses (OR: 3·47, 95% CI: 1.99–6.05. p < 0.01), paramedical staff (OR: 3·19, 95% CI: 1.93–5.28. p < 0.01) and hospital support staff (OR: 2·47, 95% CI: 1.29–4.7. p < 0.01) compared with consultants. Conclusion: Overall, our results concluded that nursing and paramedical staff are at higher risk and should be vaccinated on priority.","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25151355221080724","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Health care workers (HCWs) are exposed to high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to close contact with infected patients in hospital. The objective of this study was to estimate the seroprevalence and to identify the exposure risk of various subgroups among HCWs to prioritize them for early vaccination. Methods: This was a multicentre cross-sectional study conducted between 15 and 29 June 2020. A total of 987 HCWs were recruited randomly from two major tertiary-care hospitals of Peshawar city, Pakistan. The HCWs included doctors, nurses, paramedics and hospital support staff. The US Food and Drug Administration (FDA)–approved kit was used for the detection of SARS-CoV-2 antibodies. Results: Overall, 310 (31.4%) HCWs were seropositive for SARS-CoV-2 antibodies (95% confidence interval, CI: 28.5–34.4). Seroprevalence was higher in males (33.5%) and in age group 51–60 years (40.9%). Seropositivity increased with increasing age from 8.3% in age group ⩽20 to 40.9% in 51–60 years of age group (p < 0.05). The highest seroprevalence was identified in paramedical staff (42·5%, 95% CI: 36.6–48.6) followed by nursing staff (38·8%, 95% CI: 32.1–45.7). In logistic regression, being a male HCW led to higher risk of seropositivity (odds ratio, OR: 1.50, 95% CI: 1·06–2.13. p < 0.05) compared with female staff members. The odds of seropositivity was higher in nurses (OR: 3·47, 95% CI: 1.99–6.05. p < 0.01), paramedical staff (OR: 3·19, 95% CI: 1.93–5.28. p < 0.01) and hospital support staff (OR: 2·47, 95% CI: 1.29–4.7. p < 0.01) compared with consultants. Conclusion: Overall, our results concluded that nursing and paramedical staff are at higher risk and should be vaccinated on priority.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
确定卫生保健工作者高危亚群,优先接种COVID-19疫苗
背景:医护人员因与院内感染患者密切接触而暴露在严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染的高危人群中。本研究的目的是估计血清阳性率,并确定卫生保健工作人员中不同亚群的暴露风险,以优先考虑早期接种疫苗。方法:这是一项多中心横断面研究,于2020年6月15日至29日进行。从巴基斯坦白沙瓦市的两家主要三级医院随机招募了987名卫生保健员。医护人员包括医生、护士、护理人员和医院支援人员。使用美国食品和药物管理局(FDA)批准的试剂盒检测SARS-CoV-2抗体。结果:总体而言,310名(31.4%)医护人员SARS-CoV-2抗体血清阳性(95%置信区间,CI: 28.5-34.4)。血清阳性率在男性(33.5%)和51-60岁年龄组(40.9%)中较高。血清阳性率随年龄增长呈上升趋势,从≥20岁组的8.3%上升至51 ~ 60岁组的40.9% (p < 0.05)。血清阳性率最高的是医护人员(42.5%,95% CI: 36.6-48.6),其次是护理人员(38.8%,95% CI: 32.1-45.7)。在logistic回归中,男性HCW导致血清阳性的风险更高(优势比OR: 1.50, 95% CI: 1.06 - 2.13)。P < 0.05)。护士血清阳性的几率较高(OR: 3.47, 95% CI: 1.99 ~ 6.05)。p < 0.01),医务辅助人员(OR: 3.19, 95% CI: 1.93 ~ 5.28)。p < 0.01)和医院支持人员(OR: 2.47, 95% CI: 1.29-4.7)。P < 0.01)。结论:总体而言,我们的结果表明,护理人员和辅助医务人员的风险较高,应优先接种疫苗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy Medicine-Pharmacology (medical)
CiteScore
5.10
自引率
0.00%
发文量
15
审稿时长
8 weeks
期刊最新文献
Knowledge, attitude, and acceptance of COVID-19 vaccine in pregnant women. Comparative 60-day effectiveness of bivalent versus monovalent mRNA vaccines in Shelby County: a population-level analysis. Vaccination practices and knowledge among adults with hemoglobinopathies in Greece: a nationwide survey. Media literacy: exploring the key to social media influences for wise parental decision-making on vaccines. Monoclonal IgY antibodies: advancements and limitations for immunodiagnosis and immunotherapy applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1